Altimmune, Inc. 10-K filing
Filed 2026-03-06 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001326190-26-000018
- Form type
- 10-K
- CIK
- 0001326190
- Primary document
- https://www.sec.gov/Archives/edgar/data/1326190/000132619026000018/alt-20251231x10k.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Altimmune, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $41,000 | - | - |
| Operating Income | $-94.5M | - | - |
| Net Income | $-88.1M | - | - |
| Eps Basic | -1 | - | - |
| Eps Diluted | -1 | - | - |
| Cash And Equivalents | $43.8M | - | - |
| Total Assets | $279.9M | - | - |
| Total Liabilities | $55.0M | - | - |
| Shareholders Equity | $224.9M | - | - |
| Operating Cash Flow | $-67.5M | - | - |
| Capital Expenditures | $11,000 | - | - |